Forte Biosciences, Inc.FBRXNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank0
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-52.48M
↓ 65% vs avg
Percentile
P0
Near historical low
Streak
3 yr
Consecutive declineContracting
Average
$-31.78M
Historical baseline
PeriodValueYoY Change
TTM$-52.48M-48.1%
2024$-35.44M-9.1%
2023$-32.48M-134.3%
2022$-13.86M+35.4%
2021$-21.45M+53.8%
2020$-46.43M-1044.2%
2019$-4.06M+90.7%
2018$-43.69M-19.0%
2017$-36.70M-17.8%
2016$-31.17M-